Risk Factors Preceding Type 2 Diabetes and Cardiomyopathy

[1]  D. Kass,et al.  Advanced Glycation Endproduct Crosslinking in the Cardiovascular System , 2012, Drugs.

[2]  G. Reaven.  Syndrome X , 2012, Drugs.

[3]  R. Tsuyuki,et al.  The 2010 Canadian Hypertension Education Program (CHEP) Recommendations: Guidelines for Pharmacists , 2010 .

[4]  P. Horn,et al.  Childhood predictors of adult type 2 diabetes at 9- and 26-year follow-ups. , 2010, Archives of pediatrics & adolescent medicine.

[5]  Anita K. Sharma,et al.  IL-10 attenuates TNF-alpha-induced NF kappaB pathway activation and cardiomyocyte apoptosis. , 2009, Cardiovascular research.

[6]  S. Kono,et al.  Waist circumference and insulin resistance: a cross-sectional study of Japanese men , 2009, BMC endocrine disorders.

[7]  J. Pankow,et al.  Transcription Factor 7-Like 2 (TCF7L2) Polymorphism and Context-Specific Risk of Type 2 Diabetes in African American and Caucasian Adults , 2009, Diabetes.

[8]  K. Sourris,et al.  Interactions Between Advanced Glycation End-Products (AGE) and their Receptors in the Development and Progression of Diabetic Nephropathy – are these Receptors Valid Therapeutic Targets , 2009 .

[9]  W. Kannel,et al.  Framingham Study insights on the hazards of elevated blood pressure. , 2008, JAMA.

[10]  N. Nguyen,et al.  Association of hypertension, diabetes, dyslipidemia, and metabolic syndrome with obesity: findings from the National Health and Nutrition Examination Survey, 1999 to 2004. , 2008, Journal of the American College of Surgeons.

[11]  Jeroen J. Bax,et al.  Myocardial steatosis is an independent predictor of diastolic dysfunction in type 2 diabetes mellitus. , 2008, Journal of the American College of Cardiology.

[12]  V. Levi,et al.  Effects of phosphatidylethanolamine glycation on lipid-protein interactions and membrane protein thermal stability. , 2008, The Biochemical journal.

[13]  A. Batieha,et al.  Prevalence of dyslipidemia in patients with type 2 diabetes in Jordan. , 2008, Saudi medical journal.

[14]  Iris Shai,et al.  Changes in Triglyceride Levels Over Time and Risk of Type 2 Diabetes in Young Men , 2008, Diabetes Care.

[15]  G. Can,et al.  Predictive value of prehypertension for metabolic syndrome, diabetes, and coronary heart disease among Turks. , 2008, American journal of hypertension.

[16]  Frank B Hu,et al.  Sugar-sweetened beverages and incidence of type 2 diabetes mellitus in African American women. , 2008, Archives of internal medicine.

[17]  E. Lambert,et al.  Determinants of Insulin‐resistant Phenotypes in Normal‐weight and Obese Black African Women , 2008, Obesity.

[18]  A. Bhansali,et al.  Prevalence and predictors of metabolic syndrome in non-obese Asian Indians with newly detected type 2 diabetes mellitus. , 2008, Journal of the Indian Medical Association.

[19]  R. Petrella,et al.  A retrospective analysis of the prevalence and treatment of hypertension and dyslipidemia in Southwestern Ontario, Canada. , 2008, Clinical therapeutics.

[20]  J. Dora,et al.  Standards of Medical Care in Diabetes—2008 , 2008, Diabetes Care.

[21]  K. Khunti,et al.  Stepwise screening for diabetes identifies people with high but modifiable coronary heart disease risk. The ADDITION study , 2008, Diabetologia.

[22]  Su-Yen Goh,et al.  The role of advanced glycation end products in progression and complications of diabetes , 2008 .

[23]  R. Natarajan,et al.  Proinflammatory Effects of Advanced Lipoxidation End Products in Monocytes , 2008, Diabetes.

[24]  J. Meier,et al.  Beta cell mass in diabetes: a realistic therapeutic target? , 2008, Diabetologia.

[25]  O. Pedersen,et al.  Effect of a multifactorial intervention on mortality in type 2 diabetes. , 2008, The New England journal of medicine.

[26]  R. Witteles,et al.  Insulin-resistant cardiomyopathy clinical evidence, mechanisms, and treatment options. , 2008, Journal of the American College of Cardiology.

[27]  S. Dwivedi,et al.  Insulin response to oral glucose in healthy, lean young women and patients with polycystic ovary syndrome , 2008, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

[28]  D. Bessesen,et al.  Relationship of abdominal obesity measured by DXA and waist circumference with insulin sensitivity in Hispanic and non‐Hispanic white individuals: The San Luis Valley Diabetes Study , 2008, Diabetes/metabolism research and reviews.

[29]  Stefano Geuna,et al.  Oxidative stress triggers cardiac fibrosis in the heart of diabetic rats. , 2008, Endocrinology.

[30]  R. Muniyappa,et al.  Current approaches for assessing insulin sensitivity and resistance in vivo: advantages, limitations, and appropriate usage. , 2008, American journal of physiology. Endocrinology and metabolism.

[31]  Andy H. Lee,et al.  Predictors of type 2 diabetes and diabetes-related hospitalisation in an Australian Aboriginal cohort. , 2007, Diabetes research and clinical practice.

[32]  Xiaoming Sheng,et al.  Mitochondrial Energetics in the Heart in Obesity-Related Diabetes , 2007, Diabetes.

[33]  A. Rudich,et al.  Changes in Triglyceride Levels and Risk for Coronary Heart Disease in Young Men , 2007, Annals of Internal Medicine.

[34]  Benjamin D. Levine,et al.  Cardiac Steatosis in Diabetes Mellitus: A 1H-Magnetic Resonance Spectroscopy Study , 2007, Circulation.

[35]  M. Chapman.  Metabolic syndrome and type 2 diabetes: lipid and physiological consequences , 2007, Diabetes & vascular disease research.

[36]  T. Frayling.  Genome–wide association studies provide new insights into type 2 diabetes aetiology , 2007, Nature Reviews Genetics.

[37]  P. Nilsson,et al.  Validity and reproducibility of HOMA-IR, 1/HOMA-IR, QUICKI and McAuley's indices in patients with hypertension and type II diabetes , 2007, Journal of Human Hypertension.

[38]  R. Ware,et al.  Association between anthropometric measures of obesity and cardiovascular risk markers in a self-selected group of indigenous Australians , 2007, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.

[39]  P. Singal,et al.  Role of Advanced Glycation End Products in Hypertension and Atherosclerosis: Therapeutic Implications , 2007, Cell Biochemistry and Biophysics.

[40]  G. Bray,et al.  Reduction in Weight and Cardiovascular Disease Risk Factors in Individuals With Type 2 Diabetes , 2007, Diabetes Care.

[41]  H. Khan,et al.  Association between glycaemic control and serum lipids profile in type 2 diabetic patients: HbA1c predicts dyslipidaemia , 2007, Clinical and Experimental Medicine.

[42]  E. Randell,et al.  Plasma protein advanced glycation end products, carboxymethyl cysteine, and carboxyethyl cysteine, are elevated and related to nephropathy in patients with diabetes , 2007, Molecular and Cellular Biochemistry.

[43]  J. Danesh,et al.  Triglycerides and the Risk of Coronary Heart Disease: 10 158 Incident Cases Among 262 525 Participants in 29 Western Prospective Studies , 2007, Circulation.

[44]  A. Zabetian,et al.  Metabolic syndrome in normal-weight Iranian adults , 2006, Annals of Saudi medicine.

[45]  Heinz Schneider,et al.  Prevention and treatment of obesity with lifestyle interventions: review and meta-analysis , 2007, International Journal of Public Health.

[46]  S. Kahn,et al.  Mechanisms linking obesity to insulin resistance and type 2 diabetes , 2006, Nature.

[47]  M. Catalano,et al.  Oxidative stress-dependent impairment of cardiac-specific transcription factors in experimental diabetes. , 2006, Endocrinology.

[48]  Xianlin Han,et al.  Disruption of endoplasmic reticulum structure and integrity in lipotoxic cell death Published, JLR Papers in Press, September 7, 2006. , 2006, Journal of Lipid Research.

[49]  T. Netticadan,et al.  Alterations in cardiac contractile performance and sarcoplasmic reticulum function in sucrose-fed rats is associated with insulin resistance. , 2006, American journal of physiology. Cell physiology.

[50]  Brian Rodrigues,et al.  Role of changes in cardiac metabolism in development of diabetic cardiomyopathy. , 2006, American journal of physiology. Heart and circulatory physiology.

[51]  R. Peters,et al.  C-reactive protein levels and coronary artery disease incidence and mortality in apparently healthy men and women: the EPIC-Norfolk prospective population study 1993-2003. , 2006, Atherosclerosis.

[52]  E. Ferrannini,et al.  Fasting‐based Estimates of Insulin Sensitivity in Overweight and Obesity: A Critical Appraisal , 2006, Obesity.

[53]  Xuming Jia,et al.  Structural and functional changes in human insulin induced by methylglyoxal , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[54]  J. Manson,et al.  Ethnicity, Obesity, and Risk of Type 2 Diabetes in Women , 2006, Diabetes Care.

[55]  T. Weerarathna,et al.  Comparison of insulin resistance by indirect methods - HOMA, QUICKI and McAuley - with fasting insulin in patients with type 2 diabetes in Galle, Sri Lanka: A pilot study , 2006 .

[56]  M. Haidara,et al.  Role of oxidative stress in development of cardiovascular complications in diabetes mellitus. , 2006, Current vascular pharmacology.

[57]  P. Schwarz,et al.  Genes of Type 2 Diabetes in β Cells , 2006 .

[58]  M. T. Ghiringhello,et al.  Distribution of HOMA-IR in Brazilian subjects with different body mass indexes. , 2006, Arquivos brasileiros de endocrinologia e metabologia.

[59]  B. Geloneze,et al.  The threshold value for insulin resistance (HOMA-IR) in an admixtured population IR in the Brazilian Metabolic Syndrome Study. , 2006, Diabetes research and clinical practice.

[60]  E. Van Obberghen,et al.  Methylglyoxal Impairs the Insulin Signaling Pathways Independently of the Formation of Intracellular Reactive Oxygen Species , 2006, Diabetes.

[61]  I. Poornima,et al.  Diabetic cardiomyopathy: the search for a unifying hypothesis. , 2006, Circulation research.

[62]  R. Rizza,et al.  Relationship Between β-Cell Mass and Fasting Blood Glucose Concentration in Humans , 2006, Diabetes Care.

[63]  E. Agardh,et al.  Increased serum levels of the specific advanced glycation end product methylglyoxal-derived hydroimidazolone are associated with retinopathy in patients with type 2 diabetes mellitus. , 2006, Metabolism: clinical and experimental.

[64]  Xiaoxia Tang,et al.  Protein Adducts Generated from Products of Lipid Oxidation: Focus on HNE and ONE , 2006, Drug metabolism reviews.

[65]  Sihoon Lee,et al.  Cutoff Values of Surrogate Measures of Insulin Resistance for Metabolic Syndrome in Korean Non-diabetic Adults , 2005, Journal of Korean medical science.

[66]  R. Pandey,et al.  Waist circumference cutoff points and action levels for Asian Indians for identification of abdominal obesity , 2006, International Journal of Obesity.

[67]  Paul Zimmet,et al.  [A new international diabetes federation worldwide definition of the metabolic syndrome: the rationale and the results]. , 2005, Revista espanola de cardiologia.

[68]  I. Vauhkonen,et al.  High amount of visceral fat mass is associated with multiple metabolic changes in offspring of type 2 diabetic patients , 2005, International Journal of Obesity.

[69]  E. Abel,et al.  Reduced Mitochondrial Oxidative Capacity and Increased Mitochondrial Uncoupling Impair Myocardial Energetics in Obesity , 2005, Circulation.

[70]  L. Wold,et al.  Impaired SERCA function contributes to cardiomyocyte dysfunction in insulin resistant rats. , 2005, Journal of molecular and cellular cardiology.

[71]  Ken Williams,et al.  Nuclear Magnetic Resonance Lipoprotein Abnormalities in Prediabetic Subjects in the Insulin Resistance Atherosclerosis Study , 2005, Circulation.

[72]  K. Wellen,et al.  Inflammation, stress, and diabetes. , 2005, The Journal of clinical investigation.

[73]  P. Barter.  The inflammation: lipoprotein cycle. , 2005, Atherosclerosis. Supplements.

[74]  H. Ginsberg,et al.  Regulation of plasma triglycerides in insulin resistance and diabetes. , 2005, Archives of medical research.

[75]  Peter Arner,et al.  Use of waist circumference to predict insulin resistance: retrospective study , 2005, BMJ : British Medical Journal.

[76]  Khosrow Adeli,et al.  Fructose, insulin resistance, and metabolic dyslipidemia , 2005, Nutrition & metabolism.

[77]  Hideo Ayame,et al.  [The Da Qing IGT and Diabetes study]. , 2005, Nihon rinsho. Japanese journal of clinical medicine.

[78]  A. Siraki,et al.  Aldehyde Sources, Metabolism, Molecular Toxicity Mechanisms, and Possible Effects on Human Health , 2005, Critical reviews in toxicology.

[79]  J. Clausen,et al.  Increased methylglyoxal and advanced glycation end products in kidney from spontaneously hypertensive rats. , 2004, Kidney international.

[80]  M. Uusitupa,et al.  Comparative evaluation of simple indices of insulin resistance. , 2004, Metabolism: clinical and experimental.

[81]  D. Richards,et al.  10 YEARS AFTER , 2004, Evidence-Based Dentistry.

[82]  T. Giles,et al.  Diabetes mellitus and heart failure: basic mechanisms, clinical features, and therapeutic considerations. , 2004, Cardiology clinics.

[83]  G. Noon,et al.  Intramyocardial lipid accumulation in the failing human heart resembles the lipotoxic rat heart , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[84]  F. Marchlinski,et al.  Right Bundle-Branch Block Ventricular Tachycardias: Septal Versus Lateral Ventricular Origin Based on Activation Time to the Right Ventricular Apex , 2004, Circulation.

[85]  M. Woodward,et al.  Serum Triglycerides as a Risk Factor for Cardiovascular Diseases in the Asia-Pacific Region , 2004, Circulation.

[86]  A. McBean,et al.  Differences in diabetes prevalence, incidence, and mortality among the elderly of four racial/ethnic groups: whites, blacks, hispanics, and asians. , 2004, Diabetes care.

[87]  R. Lobo,et al.  Use of fasting blood to assess the prevalence of insulin resistance in women with polycystic ovary syndrome. , 2004, Fertility and sterility.

[88]  R. Cooksey,et al.  Impaired cardiac efficiency and increased fatty acid oxidation in insulin-resistant ob/ob mouse hearts. , 2004, Diabetes.

[89]  D. Schuster,et al.  Impaired insulin sensitivity, insulin secretion, and glucose effectiveness predict future development of impaired glucose tolerance and type 2 diabetes in pre-diabetic African Americans: implications for primary diabetes prevention. , 2004, Diabetes care.

[90]  S. Wild,et al.  Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. , 2004, Diabetes care.

[91]  E. Ford,et al.  Increased consumption of refined carbohydrates and the epidemic of type 2 diabetes in the United States: an ecologic assessment. , 2004, The American journal of clinical nutrition.

[92]  J. Berger,et al.  Treatment of type 2 diabetic db/db mice with a novel PPARgamma agonist improves cardiac metabolism but not contractile function. , 2004, American journal of physiology. Endocrinology and metabolism.

[93]  S. Harris,et al.  Recommendations from the Canadian Diabetes Association. 2003 guidelines for prevention and management of diabetes and related cardiovascular risk factors. , 2004, Canadian family physician Medecin de famille canadien.

[94]  W. Kannel,et al.  Incidence and Epidemiology of Heart Failure , 2000, Heart Failure Reviews.

[95]  S. Vasdev,et al.  Role of aldehydes in fructose induced hypertension , 1998, Molecular and Cellular Biochemistry.

[96]  D. Dekkers,et al.  Polyunsaturated fatty acids and signalling via phospholipase C-β and A2 in myocardium , 1996, Molecular and Cellular Biochemistry.

[97]  N. Khaper,et al.  Probucol treatment reverses antioxidant and functional deficit in diabetic cardiomyopathy , 1996, Molecular and Cellular Biochemistry.

[98]  K. Eriksson,et al.  Prevention of Type 2 (non-insulin-dependent) diabetes mellitus by diet and physical exercise The 6-year Malmö feasibility study , 1991, Diabetologia.

[99]  F. Cambien,et al.  Hypertriglyceridaemia as a risk factor of coronary heart disease mortality in subjects with impaired glucose tolerance or diabetes , 1989, Diabetologia.

[100]  M. King,et al.  Concordance for Type 2 (non-insulin-dependent) diabetes mellitus in male twins , 1987, Diabetologia.

[101]  R. Turner,et al.  Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man , 1985, Diabetologia.

[102]  D. Pyke,et al.  Diabetes in identical twins , 1981, Diabetologia.

[103]  D. Pyke,et al.  Diabetes in identical twins , 1981, Diabetologia.

[104]  J. Real,et al.  Diagnosing insulin resistance by simple quantitative methods in subjects with normal glucose metabolism. , 2003, Diabetes care.

[105]  Jaakko Tuomilehto,et al.  The Finnish Diabetes Prevention Study (DPS): Lifestyle intervention and 3-year results on diet and physical activity. , 2003, Diabetes care.

[106]  Jack Wang.  Waist circumference: a simple, inexpensive, and reliable tool that should be included as part of physical examinations in the doctor's office. , 2003, The American journal of clinical nutrition.

[107]  M. Laville,et al.  Modified quantitative insulin sensitivity check index is better correlated to hyperinsulinemic glucose clamp than other fasting-based index of insulin sensitivity in different insulin-resistant states. , 2003, The Journal of clinical endocrinology and metabolism.

[108]  E. Bollano,et al.  Cardiac lipid accumulation associated with diastolic dysfunction in obese mice. , 2003, Endocrinology.

[109]  J. Baynes,et al.  Maillard reaction products in tissue proteins: New products and new perspectives , 2003, Amino Acids.

[110]  Mu Wang,et al.  Chronic diabetes increases advanced glycation end products on cardiac ryanodine receptors/calcium-release channels. , 2003, Diabetes.

[111]  G. Reaven,et al.  Insulin resistance/compensatory hyperinsulinemia, essential hypertension, and cardiovascular disease. , 2003, The Journal of clinical endocrinology and metabolism.

[112]  D. Sawyer,et al.  H(2)O(2) regulates cardiac myocyte phenotype via concentration-dependent activation of distinct kinase pathways. , 2003, Journal of molecular and cellular cardiology.

[113]  Anoop Misra,et al.  Clinical and pathophysiological consequences of abdominal adiposity and abdominal adipose tissue depots. , 2003, Nutrition.

[114]  Merlin C. Thomas,et al.  A Breaker of Advanced Glycation End Products Attenuates Diabetes‐Induced Myocardial Structural Changes , 2003, Circulation research.

[115]  Sheldon Chen,et al.  Glycated albumin increases oxidative stress, activates NF-kappa B and extracellular signal-regulated kinase (ERK), and stimulates ERK-dependent transforming growth factor-beta 1 production in macrophage RAW cells. , 2003, The Journal of laboratory and clinical medicine.

[116]  Lingyun Wu,et al.  Lipoic acid prevents hypertension, hyperglycemia, and the increase in heart mitochondrial superoxide production. , 2003, American journal of hypertension.

[117]  L. Geiss,et al.  Estimated number of adults with prediabetes in the US in 2000: opportunities for prevention. , 2003, Diabetes care.

[118]  Anastasia C. Thanopoulou,et al.  Dietary fat intake as risk factor for the development of diabetes: multinational, multicenter study of the Mediterranean Group for the Study of Diabetes (MGSD). , 2003, Diabetes care.

[119]  D. Severson,et al.  Age-dependent changes in metabolism, contractile function, and ischemic sensitivity in hearts from db/db mice. , 2003, Diabetes.

[120]  D. Severson,et al.  Chylomicron and palmitate metabolism by perfused hearts from diabetic mice. , 2003, American journal of physiology. Endocrinology and metabolism.

[121]  Oluf Pedersen,et al.  Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. , 2003, The New England journal of medicine.

[122]  D. Aronson.  Cross-linking of glycated collagen in the pathogenesis of arterial and myocardial stiffening of aging and diabetes , 2003, Journal of hypertension.

[123]  P. Singal,et al.  Oxidative Stress in Cardiovascular Complications of Diabetes , 2003 .

[124]  N. Dhalla,et al.  Atherosclerosis, Hypertension and Diabetes , 2003, Progress in Experimental Cardiology.

[125]  Zhou Bei‐Fan.  Predictive values of body mass index and waist circumference for risk factors of certain related diseases in Chinese adults: study on optimal cut‐off points of body mass index and waist circumference in Chinese adults , 2002 .

[126]  A. Gotto.  High-density lipoprotein cholesterol and triglycerides as therapeutic targets for preventing and treating coronary artery disease. , 2002, American heart journal.

[127]  P. Singal,et al.  Oxidative Stress and Apoptosis in Heart Dysfunction , 2002, Herz.

[128]  S. Takasawa,et al.  Advanced glycation endproduct-induced calcium handling impairment in mouse cardiac myocytes. , 2002, Journal of molecular and cellular cardiology.

[129]  D. Severson,et al.  Cardiac function and metabolism in Type 2 diabetic mice after treatment with BM 17.0744, a novel PPAR-α activator , 2002 .

[130]  W. Shau,et al.  Optimal cut-off values for obesity: using simple anthropometric indices to predict cardiovascular risk factors in Taiwan , 2002, International Journal of Obesity.

[131]  D. Severson,et al.  Echocardiographic assessment of cardiac function in diabetic db/db and transgenic db/db-hGLUT4 mice. , 2002, American journal of physiology. Heart and circulatory physiology.

[132]  R. Krauss,et al.  Metabolic origins and clinical significance of LDL heterogeneity DOI 10.1194/jlr.R200004-JLR200 , 2002, Journal of Lipid Research.

[133]  S. Maruoka,et al.  Inverse relationship between plasma adiponectin and leptin concentrations in normal-weight and obese women. , 2002, European journal of endocrinology.

[134]  N. Ruderman,et al.  Lipid-Induced Insulin Resistance in Human Muscle Is Associated With Changes in Diacylglycerol, Protein Kinase C, and IκB-α , 2002 .

[135]  L. Ho,et al.  Waist circumference predicts insulin resistance in offspring of diabetic patients. , 2002, Diabetes, nutrition & metabolism.

[136]  R. Bergman,et al.  Extreme insulin resistance of the central adipose depot in vivo. , 2002, Diabetes.

[137]  S. Fowler,et al.  Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. , 2002 .

[138]  Peter E. Hilsenrath,et al.  The World Health Report 2000 , 2002 .

[139]  G. Lewis,et al.  The mechanism of HDL lowering in hypertriglyceridemic, insulin-resistant states. , 2002, Journal of diabetes and its complications.

[140]  A Berber,et al.  Anthropometric indexes in the prediction of type 2 diabetes mellitus, hypertension and dyslipidaemia in a Mexican population , 2001, International Journal of Obesity.

[141]  M. Quon,et al.  Repeatability characteristics of simple indices of insulin resistance: implications for research applications. , 2001, The Journal of clinical endocrinology and metabolism.

[142]  M Hørder,et al.  Randomised controlled trial of structured personal care of type 2 diabetes mellitus , 2001, BMJ : British Medical Journal.

[143]  J. Manson,et al.  Diet, lifestyle, and the risk of type 2 diabetes mellitus in women. , 2001, The New England journal of medicine.

[144]  H. Eppenberger,et al.  Glucose and palmitic acid induce degeneration of myofibrils and modulate apoptosis in rat adult cardiomyocytes. , 2001, Diabetes.

[145]  R. Hegele,et al.  Allele Frequencies for Candidate Genes in Atherosclerosis and Diabetes among Trinidadian Neonates , 2001, Human biology.

[146]  Y. Terauchi,et al.  The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity , 2001, Nature Medicine.

[147]  P. Scherer,et al.  The adipocyte-secreted protein Acrp30 enhances hepatic insulin action , 2001, Nature Medicine.

[148]  E. Boyko,et al.  Standard definitions of overweight and central adiposity for determining diabetes risk in Japanese Americans. , 2001, The American journal of clinical nutrition.

[149]  T. Valle,et al.  Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. , 2001, The New England journal of medicine.

[150]  A. Schmidt,et al.  Activation of NADPH oxidase by AGE links oxidant stress to altered gene expression via RAGE. , 2001, American journal of physiology. Endocrinology and metabolism.

[151]  R. Walker,et al.  Diagnosing insulin resistance in the general population. , 2001, Diabetes care.

[152]  H. Lodish,et al.  Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[153]  L. Kirshenbaum,et al.  Apoptosis in adriamycin cardiomyopathy and its modulation by probucol. , 2001, Antioxidants & redox signaling.

[154]  I. Okosun.  Racial Differences in Rates of Type 2 Diabetes in American Women: How much is due to differences in overall adiposity? , 2001, Ethnicity & health.

[155]  A. Astrup,et al.  Obesity : Preventing and managing the global epidemic , 2000 .

[156]  D. Severson,et al.  Altered metabolism causes cardiac dysfunction in perfused hearts from diabetic (db/db) mice. , 2000, American journal of physiology. Endocrinology and metabolism.

[157]  J. Flier,et al.  Obesity and insulin resistance. , 2000, The Journal of clinical investigation.

[158]  D. Gaudet,et al.  Hypertriglyceridemic waist: A marker of the atherogenic metabolic triad (hyperinsulinemia; hyperapolipoprotein B; small, dense LDL) in men? , 2000, Circulation.

[159]  J. Seidell,et al.  Obesity, insulin resistance and diabetes — a worldwide epidemic , 2000, British Journal of Nutrition.

[160]  T Nakamura,et al.  Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[161]  D. Rudy,et al.  Intracellular mechanisms regulating apoB-containing lipoprotein assembly and secretion in primary hamster hepatocytes. , 2000, Journal of lipid research.

[162]  K. Ohmori,et al.  Alteration in left ventricular diastolic filling and accumulation of myocardial collagen at insulin-resistant prediabetic stage of a type II diabetic rat model. , 2000, Circulation.

[163]  L. Orci,et al.  Lipotoxic heart disease in obese rats: implications for human obesity. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[164]  A. Golay,et al.  Acute hyperinsulinemia and very-low-density and low-density lipoprotein subfractions in obese subjects. , 2000, The American journal of clinical nutrition.

[165]  E. Bonora,et al.  Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. , 2000, Diabetes care.

[166]  S. Wannamethee,et al.  Weight change and duration of overweight and obesity in the incidence of type 2 diabetes. , 1999, Diabetes care.

[167]  B. Howard.  Insulin resistance and lipid metabolism. , 1999, The American journal of cardiology.

[168]  M. Taskinen,et al.  Postprandial Hypertriglyceridemia and Insulin Resistance in Normoglycemic First-Degree Relatives of Patients with Type 2 Diabetes , 1999, Annals of Internal Medicine.

[169]  L. Kirshenbaum,et al.  Apoptosis in Isolated Adult Cardiomyocytes Exposed to Adriamycin a , 1999, Annals of the New York Academy of Sciences.

[170]  G. Shulman,et al.  Free fatty acid-induced insulin resistance is associated with activation of protein kinase C theta and alterations in the insulin signaling cascade. , 1999, Diabetes.

[171]  A. Schmidt,et al.  Activation of receptor for advanced glycation end products: a mechanism for chronic vascular dysfunction in diabetic vasculopathy and atherosclerosis. , 1999, Circulation research.

[172]  O. Pedersen,et al.  Intensified multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: the Steno type 2 randomised study , 1999, The Lancet.

[173]  H. Lebovitz,et al.  Body composition, visceral fat, leptin, and insulin resistance in Asian Indian men. , 1999, The Journal of clinical endocrinology and metabolism.

[174]  Bruce Neal,et al.  1999 World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension. Guidelines Subcommittee. , 1999, Journal of hypertension.

[175]  L. Niskanen,et al.  Hyperglycemia and compositional lipoprotein abnormalities as predictors of cardiovascular mortality in type 2 diabetes: a 15-year follow-up from the time of diagnosis. , 1998, Diabetes care.

[176]  B. La Du,et al.  Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase. , 1998, The Journal of clinical investigation.

[177]  P. Flatt,et al.  Glycation of insulin results in reduced biological activity in mice , 1997, Acta Diabetologica.

[178]  L. Groop,et al.  Characterization of the prediabetic state. , 1997, American journal of hypertension.

[179]  G. Shulman,et al.  Metabolic Defects in Lean Nondiabetic Offspring of NIDDM Parents: A Cross-Sectional Study , 1997, Diabetes.

[180]  E. Ferrannini,et al.  Insulin resistance is central to the burden of diabetes. , 1997, Diabetes/metabolism reviews.

[181]  C A Beltrami,et al.  Apoptosis in the failing human heart. , 1997, The New England journal of medicine.

[182]  B. Howard,et al.  Effects of Diet and Exercise in Preventing NIDDM in People With Impaired Glucose Tolerance: The Da Qing IGT and Diabetes Study , 1997, Diabetes Care.

[183]  S. Haffner,et al.  A Prospective Analysis of the HOMA Model: The Mexico City Diabetes Study , 1996, Diabetes Care.

[184]  S. Kasim-Karakas,et al.  Effects of dietary carbohydrates on glucose and lipid metabolism in golden Syrian hamsters. , 1996, The Journal of laboratory and clinical medicine.

[185]  G. Bondjers,et al.  Accumulation of lipoprotein fractions and subfractions in the arterial wall, determined in an in vitro perfusion system. , 1996, Atherosclerosis.

[186]  M. Laakso,et al.  Prospective study of small LDLs as a risk factor for non-insulin dependent diabetes mellitus in elderly men and women. , 1995, Circulation.

[187]  N. Khaper,et al.  Probucol improves antioxidant activity and modulates development of diabetic cardiomyopathy. , 1995, Nutrition.

[188]  J. Bajaj,et al.  Pattern of non-insulin dependent diabetes mellitus in Kuwait. , 1995, Diabetes research and clinical practice.

[189]  L. Groop,et al.  Metabolic and genetic characterization of prediabetic states. Sequence of events leading to non-insulin-dependent diabetes mellitus. , 1994, The Journal of clinical investigation.

[190]  G. Striker,et al.  Advanced glycation end products up-regulate gene expression found in diabetic glomerular disease. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[191]  D. Janero,et al.  Hydroperoxide-induced oxidative stress impairs heart muscle cell carbohydrate metabolism. , 1994, The American journal of physiology.

[192]  P. Singal,et al.  Free radicals and the heart. , 1993, Journal of pharmacological and toxicological methods.

[193]  Lippincott Williams Wilkins,et al.  1993 guidelines for the management of mild hypertension. Memorandum from a World Health Organization/International Society of Hypertension meeting. Guidelines Subcommittee of the WHO/ISH Mild Hypertension Liaison Committee. , 1993, Hypertension.

[194]  S. Haffner,et al.  Incidence of NIDDM and Impaired Glucose Tolerance in Hypertensive Subjects: The San Antonio Heart Study , 1993, Diabetes.

[195]  Paul J Thornalley.  The glyoxalase system in health and disease. , 1993, Molecular aspects of medicine.

[196]  R. Blakytny,et al.  Glycation (non-enzymic glycosylation) inactivates glutathione reductase. , 1992, The Biochemical journal.

[197]  R. Dargel.  Lipid peroxidation--a common pathogenetic mechanism? , 1992, Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie.

[198]  G. Reaven,et al.  Prevalence of hyperinsulinaemia in patients with high blood pressure , 1992, Journal of internal medicine.

[199]  Y. Suzuki,et al.  Inhibition of Ca(2+)-ATPase of vascular smooth muscle sarcoplasmic reticulum by reactive oxygen intermediates. , 1991, The American journal of physiology.

[200]  M. Hanefeld,et al.  Diabetes Intervention Study: Multi-Intervention Trial in Newly Diagnosed NIDDM , 1991, Diabetes Care.

[201]  H. Esterbauer,et al.  Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. , 1991, Free radical biology & medicine.

[202]  A Tremblay,et al.  Regional distribution of body fat, plasma lipoproteins, and cardiovascular disease. , 1990, Arteriosclerosis.

[203]  N. Dhalla,et al.  Reduction of calcium channel antagonist binding sites by oxygen free radicals in rat heart. , 1989, Journal of molecular and cellular cardiology.

[204]  L. Groop,et al.  Early metabolic defects in persons at increased risk for non-insulin-dependent diabetes mellitus. , 1989, The New England journal of medicine.

[205]  V. Mohan,et al.  Prevalence of non-insulin-dependent diabetes mellitus in Asian Indian families with a single diabetic parent. , 1988, Diabetes research and clinical practice.

[206]  S. Teutsch,et al.  The control of hypertension in persons with diabetes: a public health approach. , 1987, Public health reports.

[207]  E. Ferrannini,et al.  Insulin resistance in essential hypertension. , 1987, The New England journal of medicine.

[208]  S. Vasdev,et al.  Myocardial lesions induced by prolonged alcohol feeding in rhesus monkeys. , 1975, Cardiovascular research.

[209]  W. Kannel,et al.  Role of diabetes in congestive heart failure: the Framingham study. , 1974, The American journal of cardiology.

[210]  J. Vague,et al.  The degree of masculine differentiation of obesities: a factor determining predisposition to diabetes, atherosclerosis, gout, and uric calculous disease. , 1956, The American journal of clinical nutrition.